文献速递中药与中成药合理使用中医内科中医骨伤

藤类中药药用规律定量研究

Medicinal patterns of vines used in Chinese herbal medicine: a quantitative study.
PubMed 文献 · J Ethnopharmacol · 2023-10-11

该研究从药物标准与目录数据库检索藤类药材,经World Flora Online规范学名后定量分析其药用部位、传统功能、临床谱、化学成分、药理及毒性特征,共纳入36科77属133种121味药材,发现豆科、防己科、茜草科为优势科,茎为主要药用部位,祛风为传统功能核心节点,抗炎抗关节炎作用突出,并提示藤类在风湿病外多种疾病中的开发潜力。

要点

  • 藤类药材以茎为主,祛风为传统功能网络核心节点。
  • 抗炎与抗关节炎是藤类治疗风湿病的主要药理方向。
  • 藤类药用范围超越关节炎,涉及多系统疾病。

核心结论

  • 藤类中药是中药的重要来源,适用于关节炎和风湿病之外的多种临床表现。
  • 除茎外,其他部位也常用于药物和膳食补充剂。
  • 藤类植物为开发增值药物提供了广泛的生物相关化学空间。

研究设计与样本

  • 研究从药物标准与 curated catalogues 数据库检索药用藤类,经 World Flora Online 规范学名后定量分析。
  • 共纳入36科77属133种藤类植物的121味药材。

主要发现

  • 豆科、防己科和茜草科是药用藤类中排名最高的科。
  • 茎是最主要的药用部位。
  • 祛风在传统功能共现网络中显示为中心节点。
  • 藤类除关节痹病外,对多种器官系统疾病显示广泛治疗作用。
  • 抗炎和抗关节炎作用在治疗风湿性疾病中尤为突出。

关键数值与推荐

  • 共分析121味药材,来自36科77属133种藤类植物。
  • 豆科、防己科和茜草科为排名最高的科。
  • 茎为最主导的药用部位。
  • 祛风为传统功能共现网络的中心节点。

临床怎么用

  • 藤类中药可考虑用于风湿性疾病以外的多系统病症。
  • 藤类除茎外其他部位也可用于药物和膳食补充剂开发。
  • 藤类植物化学多样性可为新药研发提供候选空间。

局限性

  • 基于数据库与目录的定量分析,可能受数据完整性与规范化的限制。
  • 藤类从古代民族医学证据向现代医学体系的转化尚未充分建立。
  • 部分藤类物种为已知有毒植物,需注意安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: The botanical characteristics of twinning, climbing vine plants conceptually take shape to interlink the meridians and collaterals system throughout the human body by expelling climatic evils (e.g., wind, dampness). Thus, vines have displayed great medicinal properties in traditional Chinese medicine (TCM). AIM OF THE STUDY: Although some popular vine species have been intensively investigated, the comparable features and medicinal specifications among a vast collection of taxonomic groups based on data visualization methods are relatively lacking in attention. Moreover, the translatability of vines from ancient ethnomedical evidence to modern medical system has not been well established. This review tends to quantitatively summarize the strength of vines in healthcare from the perspectives of medicinal part, traditional function, clinical spectrum, phytochemistry divergence, pharmacological attributes, toxicity as well as the progress of proprietary drug development. MATERIALS AND METHODS: Medicinal vines were retrieved from databases of drug standards and curated catalogues. Synonyms of plant origin across different datasets were normalized by accepted scientific names in the World Flora Online. The distribution patterns and rank of plant origin, medicinal parts, traditional functions and target conditions, as well as the correlation between phytochemical composition and clinical applications were analyzed and visualized. RESULTS: A total of 121 crude drugs from 36 families, 77 genera, 133 species of vines were obtained and analyzed. The Fabaceae, Menispermaceae and Rubiaceae were the highest ranked families of medicinal vines. Not surprisingly, stem was the most dominant medical part. Moreover, "eliminate wind" displayed a hub node in the traditional function co-occurrence network. In addition to joint impediment disorders, these vines particularly displayed a wide range of therapeutic modalities toward conditions from various organ systems. Chemotaxonomic properties-oriented phytochemical analysis was performed and the chemical diversity among medicinal vines complementarily determined a certain group of therapeutic domains. Particularly, the anti-inflammatory effect and antiarthritic effect were highlighted for treating rheumatic diseases. Using integral animal models and cultured cells, modern pharmacological actions of medicinal vines have been largely observed and validated according to their traditional ethnopharmacology. Furthermore, a small proportion of vine species are well-known toxic plants. Successful drug development pipelines in rheumatic, cardiovascular, liver, malignant and infectious diseases have offered the capacity to generate new treatment options that are being sought out from vine plants. CONCLUSIONS: Medicinal vines are rich sources of Chinese Material Medica (CMM) and good fit for a variety of clinical manifestations beyond arthritis and rheumatic diseases. In addition to stem, other parts are also popular for both medicines and dietary supplements. Vine plants provide extensive biologically relevant chemical space for developing value-creating drugs. Thus, our analysis can be useful for further motivating and strengthening the preclinical and clinical research of vine-derived remedies.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Ding Y, Zhao D, Wang T, et al. Medicinal patterns of vines used in Chinese herbal medicine: a quantitative study. J Ethnopharmacol. 2023. PMID: 37827301. doi:10.1016/j.jep.2023.117184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。